Germany says production capacity, not patents, key to upping vaccine output
FILE PHOTO: A health worker checks the temperature of the nurse before vaccination, in the state of Brandenburg where the first coronavirus vaccinations are given in doctors' surgeries, in Senftenberg, Germany, March 3, 2021. REUTERS/Hannibal Hanschke/Pool
The main challenge to raising production of Covid-19 vaccines is how to quickly and effectively transfer technology, Germany's health minister said Friday, reiterating Berlin's opposition to a US proposal to waive patent protection.
"The main issue is not patent protection but production capacity," Jens Spahn told a news conference on Friday.
In a jab at the Biden administration, Spahn also said: "I would be delighted if the United States shows the same willingness to export vaccines that we in Germany do."
Keep updated, follow The Business Standard's Google news channel
